Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809
- Citation:
- Eur J Cancer vol 47 (5) 683-689
- Year:
- 2011
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- 338
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- R29 CA060050-06
- Corr. Author:
- Authors:
- C. L. Shapiro S. Halabi V. Hars L. Archer D. Weckstein J. Kirshner W. Sikov E. Winer H.J. Burstein C. Hudis C. Isaacs R. Schilsky E. Paskett
- Networks:
- Study
- CALGB-79809
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Article